CD8+ cytotoxic T lymphocytes (CTLs) have T cell receptors that directly recognize tumor-specific antigens displayed on cell surface major histocompatibility complexes (MHC) class I molecules of cancer cells [1071]. This evidence concerns the gene CD8A and cancer.